# Enliven Therapeutics, Inc.: Form DEF 14A, filed Apr 26, 2024

- Company: [Enliven Therapeutics, Inc.](/companies/elvn.md) (CIK 1672619)
- Form: DEF 14A
- Filed: 2024-04-26
- Accepted by EDGAR: Apr 26, 2024, 16:05 ET
- Period: 2024-06-18
- Accession: 0001193125-24-117969
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1672619/000119312524117969/d746513ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1672619/000119312524117969/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1672619/000119312524117969/d746513ddef14a.htm

Filed Apr 26, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-117969. Last ingested by Listed: Nov 5, 2026, 17:49 ET. No prices; not investment advice.
